These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [Fluoroquinolones--a new and important group of antimicrobial agents]. Sander J. Tidsskr Nor Laegeforen; 1992 Jan 30; 112(3):346-9. PubMed ID: 1553674 [Abstract] [Full Text] [Related]
11. In vivo activity of ciprofloxacin, ofloxacin, norfloxacin and pipemidic acid against Escherichia coli infections in mice. Obana Y, Nishino T. Drugs Exp Clin Res; 1989 Jan 30; 15(2):53-8. PubMed ID: 2661182 [Abstract] [Full Text] [Related]
12. Do we need an intravenous fluoroquinolone? Maddix DS, Warner L. West J Med; 1992 Jul 30; 157(1):55-9. PubMed ID: 1413744 [Abstract] [Full Text] [Related]
19. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit. Sader HS, Jones RN, Dowzicky MJ, Fritsche TR. Diagn Microbiol Infect Dis; 2005 Jul 30; 52(3):203-8. PubMed ID: 16105565 [Abstract] [Full Text] [Related]
20. Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Committee on Antimicrobial Agents. Canadian Infectious Disease Society. Louie TJ. CMAJ; 1994 Mar 01; 150(5):669-76. PubMed ID: 8313286 [Abstract] [Full Text] [Related] Page: [Next] [New Search]